Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lynch

Showing results (811-820 of 863) with videos related to

Pageof 87
Sort By:
Molecular Cell|January 24, 2012
Intragenic enhancers act as alternative promotersMonika S Kowalczyk, Jim R Hughes, David Garrick, et al.
Human Reproduction (Oxford, England)|February 1, 2017
Is human fecundity changing? A discussion of research and data gaps precluding us from having an answerMelissa M Smarr, Katherine J Sapra, Alison Gemmill, et al.
Genetic Testing|January 1, 1997
The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patientsD M McDonald-McGinn, D LaRossa, E Goldmuntz, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 31, 2014
A lexicon of assessment and outcome measures for telemental healthJay H Shore, Matt C Mishkind, Jordana Bernard, et al.
Cancer Discovery|February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLeanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Pageof 87

Showing results (811-820 of 863) with videos related to

Sort By:
Pageof 87
Molecular Cell|January 24, 2012
Intragenic enhancers act as alternative promotersMonika S Kowalczyk, Jim R Hughes, David Garrick, et al.
Human Reproduction (Oxford, England)|February 1, 2017
Is human fecundity changing? A discussion of research and data gaps precluding us from having an answerMelissa M Smarr, Katherine J Sapra, Alison Gemmill, et al.
Genetic Testing|January 1, 1997
The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patientsD M McDonald-McGinn, D LaRossa, E Goldmuntz, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|January 31, 2014
A lexicon of assessment and outcome measures for telemental healthJay H Shore, Matt C Mishkind, Jordana Bernard, et al.
Cancer Discovery|February 13, 2015
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway AlterationsLeanne G Ahronian, Erin M Sennott, Eliezer M Van Allen, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Pageof 87